Wednesday, July 8, 2026

Drug profile · INN

pentagastrin

pentagastrin (PEPTAVLON) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 3
Pipeline programs 0
News articles 0
Drug details — pentagastrin
US status
approved
Class
Route
INJECTION
Patents
3
Programs
0
Data quality
0.84

Quick answer

pentagastrin (PEPTAVLON) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN pentagastrin
Brand PEPTAVLON
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Related patents

  1. US 8853356

    Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7807623

    Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7365047

    Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

    Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is pentagastrin?

pentagastrin (PEPTAVLON) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for pentagastrin?

PEPTAVLON is a marketed brand name for pentagastrin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of pentagastrin?

pentagastrin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.